
-
Asalanka ton leads Sri Lanka to 244 in first Bangladesh ODI
-
UK govt backs finance minister after tears in parliament
-
US private sector shed jobs for first time in recent years: ADP
-
Chelsea sign Brazil striker Joao Pedro from Brighton
-
Farrell says slow-starting Lions still have work to do
-
French court convicts ex-Ubisoft bosses for workplace harassment
-
Freeman at the double as slick Lions romp past Reds 52-12
-
India's Jaiswal on the attack against England in second Test
-
Liverpool defender Quansah signs for Bayer Leverkusen
-
Alcaraz aims to avoid giant-killing after Wimbledon seeds tumble
-
Freeman at the double as Lions sweep past Queensland Reds 52-12
-
Iran ends cooperation with UN nuclear watchdog after Israel, US strikes
-
Matildas' defender Carpenter leaves Lyon for Chelsea
-
Public or private? Funding debate splits reeling aid sector
-
Stocks diverge as tariffs deadline looms
-
EU unveils long-delayed 2040 climate target -- with wiggle room
-
Central Europe swelters as heatwave moves east
-
Hong Kong to regain IPO crown this year, say PwC and Deloitte
-
Iran suspends cooperation with UN nuclear watchdog
-
Israel's top diplomat urges seizing chance after Trump ceasefire push
-
Australia cancels Kanye West visa over 'Heil Hitler' song
-
Israel FM calls to seize opportunity as Trump pushes for Gaza ceasefire
-
Fire that closed Heathrow traced to unrepaired transformer
-
Gaza rescuers say Israeli strikes kill 14 as Trump teases ceasefire push
-
Asian markets mixed as trade deal cut-off looms
-
Dalai Lama says he will have successor after his death
-
Demining Ukraine: from drones to risking it with a rake
-
Eggs en Provence: France's unique dinosaur egg trove
-
'I lost my battle': warming sea killing Albania fishing
-
Combs Trial: Day three of jury debate after partial verdict reached
-
Giant Trump tax bill faces make-or-break vote in Congress
-
Oasis: five favourite hits
-
'Finally': Oasis fans, young and old, gear up for reunion
-
North Korea opens massive beach resort: state media
-
'No roof' to Savea ability for ex-All Black Kaino before France Tests
-
Alcaraz faces amateur hour against young Brit at Wimbledon
-
'Writing is thinking': do students who use ChatGPT learn less?
-
Australian airline Qantas says hit by 'significant' cyberattack
-
India exporters cautiously optimistic as US tariff deadline looms
-
Real Madrid oust Juventus as Dortmund reach Club World Cup quarters
-
Relief coming for Europe after brutal heatwave
-
Fate of major trade deal with EU hangs over Mercosur summit
-
Thai veteran politician set for single day as acting PM
-
Guirassy double as Dortmund down Monterrey to reach Club World Cup quarters
-
BTS agency confirms superstars' 2026 album, tour
-
US halting some shipments of military aid to Ukraine
-
ALMA lets astronomers see building blocks of early galaxies
-
Philippines biodiversity hotspot pushes back on mining
-
Deal or no deal: What happens with Trump's July tariff deadline?
-
Canada turns to drones for reforestation after wildfires

US pharmacy chains announce abortion pill rollout
America's two biggest pharmacy chains said Friday they will begin dispensing prescription abortion pills in a limited number of states where it's legal.
The move greatly broadens availability of the drug mifepristone, even as a legal case over whether it was properly approved two decades ago now rests before the Supreme Court.
Walgreens "expects to begin dispensing within a week" in New York, Pennsylvania, Massachusetts, California, and Illinois, the company said on its website.
"But in the interests of pharmacist and patient safety, we will not disclose the number of sites per state nor identify the pharmacies that are dispensing," it added.
A CVS spokesperson told AFP: "We'll begin filling prescriptions for the medication in Massachusetts and Rhode Island in the weeks ahead and will expand to additional states, where allowed by law, on a rolling basis."
The Food and Drug Administration (FDA) authorized pharmacies to carry mifepristone in January 2023, with Friday's announcements the results of a long certification process.
Mifepristone works to block a pregnancy, while a second drug, misoprostol, provokes bleeding to empty the uterus and was already widely available in pharmacies.
The news was hailed by President Joe Biden, who has made protecting reproductive rights a key part of his re-election campaign against the likely Republican candidate Donald Trump.
Trump tipped the balance of the Supreme Court during his own presidency and paved the way for reversal of the national right to abortion.
"With major retail pharmacy chains newly certified to dispense medication abortion, many women will soon have the option to pick up their prescription at a local, certified pharmacy -- just as they would for any other medication," Biden said in a statement.
"The stakes could not be higher for women across America. In the face of relentless attacks on reproductive freedom by Republican elected officials, Vice President Harris and I will continue to fight to ensure that women can get the health care they need."
The US Supreme Court overturned the nationwide right to abortion in 2022, allowing each state to pass its own laws governing the procedure.
Twenty-one states have since banned or moved to restrict abortions to limits tighter than before Roe v Wade, the previous case that upheld the constitutional right to terminate a pregnancy.
Abortion pills remain illegal in states where the procedure is prohibited. But women who decide to travel to a state where abortion is legal may now find a pharmacy much closer than an abortion clinic, reducing their travel.
The Supreme Court will hear arguments March 26 in a case brought by anti-abortion groups to restrict access to mifepristone, first approved in the year 2000 and used by more than 5.6 million Americans since.
D.Moore--AMWN